Article Text

other Versions

Female Anderson–Fabry disease mimicking hypertrophic cardiomyopathy
  1. L Keeling1,
  2. S K Suvarna1,
  3. D A Hughes2
  1. 1Department of Histopathology, Sheffield Teaching Hospitals, Northern General Hospital, Sheffield, UK
  2. 2Department of Haematology, Lysosomal Storage Disorders Unit, Royal Free Hospital, University College London, London, UK
  1. Correspondence to Dr S K Suvarna, Department of Histopathology, Sheffield Teaching Hospitals, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK; s.k.suvarna{at}

Statistics from

Anderson–Fabry disease is a lysosomal storage disorder caused by mutation in the GLA (α-galactosidase A) gene. Inheritance is X-linked and results in accumulation of glycosphingolipids, ultimately causing cellular dysfunction, inflammation, fibrosis and progressive organ dysfunction. Storage in vascular endothelial cells causes further tissue damage due to poor perfusion.

Classically it presents in young men with acroparasthesia, skin phenomena (angiokeratoma and hypohydrosis), gastrointestinal symptoms and renal failure.1 However, it is heterogeneous in presentation and some late-onset variants, affecting a single organ, have been described. Furthermore, the effect on women has now been recognised, with some being as severely affected as men.2 This may at least in part result from skewing of X-inactivation (lyonisation). Prior to modern transplantation and dialysis, Anderson–Fabry disease was untreatable. More recently enzyme replacement therapy with the missing α-galactosidase A has been reported to have beneficial effects on symptoms, organ function and architecture.3–5

We describe here the role of the autopsy in the diagnosis …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.